Zhongchao Inc. (NASDAQ: ZCMD) Stock Competitors & Peer Comparison
See ZCMD's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for ZCMD and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ZCMD | $1.40 | -19.08% | 48.6K | -0.05 | -$29.70 | N/A |
| VEEV | $186.24 | +3.71% | 30.3B | 22.37 | $8.33 | N/A |
| GEHC | $60.58 | -2.27% | 27.6B | 13.29 | $4.56 | +0.23% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $72.91 | +4.40% | 14.3B | 58.80 | $1.24 | N/A |
| BTSGU | $238.26 | +3.48% | 14.2B | 215.44 | $1.11 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $94.64 | +0.32% | 7.9B | 22.11 | $4.28 | N/A |
| TEM | $42.69 | -7.22% | 7.5B | -85.38 | -$0.50 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
ZCMD vs VEEV Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, VEEV has a market cap of 30.3B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while VEEV trades at $186.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas VEEV's P/E ratio is 22.37. In terms of profitability, ZCMD's ROE is -0.32%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, ZCMD is more volatile compared to VEEV. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
ZCMD vs GEHC Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, GEHC has a market cap of 27.6B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while GEHC trades at $60.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas GEHC's P/E ratio is 13.29. In terms of profitability, ZCMD's ROE is -0.32%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, ZCMD is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
ZCMD vs GEHCV Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas GEHCV's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, ZCMD is more volatile compared to GEHCV. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
ZCMD vs BTSG Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, BTSG has a market cap of 14.3B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while BTSG trades at $72.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas BTSG's P/E ratio is 58.80. In terms of profitability, ZCMD's ROE is -0.32%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, ZCMD is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
ZCMD vs BTSGU Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, BTSGU has a market cap of 14.2B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while BTSGU trades at $238.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas BTSGU's P/E ratio is 215.44. In terms of profitability, ZCMD's ROE is -0.32%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, ZCMD is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check BTSGU's competition here
Signify Health, Inc. (NYSE: SGFY)
ZCMD vs SGFY Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas SGFY's P/E ratio is 70.91. In terms of profitability, ZCMD's ROE is -0.32%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, ZCMD is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
ZCMD vs HQY Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, HQY has a market cap of 7.9B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while HQY trades at $94.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas HQY's P/E ratio is 22.11. In terms of profitability, ZCMD's ROE is -0.32%, compared to HQY's ROE of +0.11%. Regarding short-term risk, ZCMD is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check HQY's competition here
Tempus AI, Inc. (NASDAQ: TEM)
ZCMD vs TEM Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, TEM has a market cap of 7.5B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while TEM trades at $42.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas TEM's P/E ratio is -85.38. In terms of profitability, ZCMD's ROE is -0.32%, compared to TEM's ROE of -0.70%. Regarding short-term risk, ZCMD is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check TEM's competition here
R1 RCM Inc. (NASDAQ: RCM)
ZCMD vs RCM Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, RCM has a market cap of 6B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas RCM's P/E ratio is -102.21. In terms of profitability, ZCMD's ROE is -0.32%, compared to RCM's ROE of +0.00%. Regarding short-term risk, ZCMD is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
ZCMD vs TXG Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, TXG has a market cap of 5.9B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while TXG trades at $46.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas TXG's P/E ratio is -272.18. In terms of profitability, ZCMD's ROE is -0.32%, compared to TXG's ROE of -0.03%. Regarding short-term risk, ZCMD is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
ZCMD vs HNGE Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, HNGE has a market cap of 5.8B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while HNGE trades at $74.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas HNGE's P/E ratio is 38.12. In terms of profitability, ZCMD's ROE is -0.32%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, ZCMD is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check HNGE's competition here
Doximity, Inc. (NYSE: DOCS)
ZCMD vs DOCS Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, DOCS has a market cap of 3.8B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while DOCS trades at $20.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas DOCS's P/E ratio is 13.35. In terms of profitability, ZCMD's ROE is -0.32%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, ZCMD is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
ZCMD vs ONEM Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas ONEM's P/E ratio is -7.77. In terms of profitability, ZCMD's ROE is -0.32%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, ZCMD is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
ZCMD vs PRVA Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, PRVA has a market cap of 3.2B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while PRVA trades at $25.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas PRVA's P/E ratio is 159.38. In terms of profitability, ZCMD's ROE is -0.32%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, ZCMD is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
ZCMD vs PGNY Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, PGNY has a market cap of 2.4B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while PGNY trades at $31.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas PGNY's P/E ratio is 22.77. In terms of profitability, ZCMD's ROE is -0.32%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, ZCMD is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
ZCMD vs HTFL Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, HTFL has a market cap of 2.1B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while HTFL trades at $24.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas HTFL's P/E ratio is -12.00. In terms of profitability, ZCMD's ROE is -0.32%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, ZCMD is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
ZCMD vs WGS Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, WGS has a market cap of 1.8B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while WGS trades at $59.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas WGS's P/E ratio is 69.53. In terms of profitability, ZCMD's ROE is -0.32%, compared to WGS's ROE of -0.28%. Regarding short-term risk, ZCMD is more volatile compared to WGS. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check WGS's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
ZCMD vs NXGN Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas NXGN's P/E ratio is -266.00. In terms of profitability, ZCMD's ROE is -0.32%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, ZCMD is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check NXGN's competition here
Teladoc Health, Inc. (NYSE: TDOC)
ZCMD vs TDOC Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, TDOC has a market cap of 1.6B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while TDOC trades at $8.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas TDOC's P/E ratio is -9.75. In terms of profitability, ZCMD's ROE is -0.32%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, ZCMD is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check TDOC's competition here
Agiliti, Inc. (NYSE: AGTI)
ZCMD vs AGTI Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas AGTI's P/E ratio is -71.79. In terms of profitability, ZCMD's ROE is -0.32%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, ZCMD is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check AGTI's competition here
Omada Health (NASDAQ: OMDA)
ZCMD vs OMDA Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, OMDA has a market cap of 1.2B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while OMDA trades at $20.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas OMDA's P/E ratio is 293.29. In terms of profitability, ZCMD's ROE is -0.32%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, ZCMD is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check OMDA's competition here
Certara, Inc. (NASDAQ: CERT)
ZCMD vs CERT Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, CERT has a market cap of 1.2B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while CERT trades at $7.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas CERT's P/E ratio is 19.26. In terms of profitability, ZCMD's ROE is -0.32%, compared to CERT's ROE of -0.01%. Regarding short-term risk, ZCMD is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
ZCMD vs GDRX Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, GDRX has a market cap of 1B. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while GDRX trades at $2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas GDRX's P/E ratio is 8.97. In terms of profitability, ZCMD's ROE is -0.32%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, ZCMD is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check GDRX's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
ZCMD vs CCLDO Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas CCLDO's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, ZCMD is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
ZCMD vs HSTM Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, HSTM has a market cap of 792.8M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while HSTM trades at $27.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas HSTM's P/E ratio is 35.70. In terms of profitability, ZCMD's ROE is -0.32%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, ZCMD is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check HSTM's competition here
Phreesia, Inc. (NYSE: PHR)
ZCMD vs PHR Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, PHR has a market cap of 632.6M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while PHR trades at $10.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas PHR's P/E ratio is 36.55. In terms of profitability, ZCMD's ROE is -0.32%, compared to PHR's ROE of +0.03%. Regarding short-term risk, ZCMD is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check PHR's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
ZCMD vs MPLN-WT Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, ZCMD is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
ZCMD vs ACCD Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas ACCD's P/E ratio is -3.08. In terms of profitability, ZCMD's ROE is -0.32%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, ZCMD is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
ZCMD vs SHCR Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas SHCR's P/E ratio is -3.76. In terms of profitability, ZCMD's ROE is -0.32%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, ZCMD is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SHCR's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
ZCMD vs WGSWW Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, WGSWW has a market cap of 514.5M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas WGSWW's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, ZCMD is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check WGSWW's competition here
Evolent Health, Inc. (NYSE: EVH)
ZCMD vs EVH Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, EVH has a market cap of 474.7M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while EVH trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas EVH's P/E ratio is 422.00. In terms of profitability, ZCMD's ROE is -0.32%, compared to EVH's ROE of -0.78%. Regarding short-term risk, ZCMD is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check EVH's competition here
NRC Health (NASDAQ: NRC)
ZCMD vs NRC Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, NRC has a market cap of 474.2M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while NRC trades at $21.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas NRC's P/E ratio is 25.66. In terms of profitability, ZCMD's ROE is -0.32%, compared to NRC's ROE of +0.57%. Regarding short-term risk, ZCMD is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check NRC's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
ZCMD vs SLGC Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas SLGC's P/E ratio is -3.04. In terms of profitability, ZCMD's ROE is -0.32%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, ZCMD is more volatile compared to SLGC. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
ZCMD vs SLGCW Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, ZCMD's ROE is -0.32%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, ZCMD is more volatile compared to SLGCW. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
ZCMD vs TBRG Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas TBRG's P/E ratio is 9.37. In terms of profitability, ZCMD's ROE is -0.32%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, ZCMD is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check TBRG's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
ZCMD vs SOPH Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, SOPH has a market cap of 393.2M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while SOPH trades at $5.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas SOPH's P/E ratio is -11.00. In terms of profitability, ZCMD's ROE is -0.32%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, ZCMD is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SOPH's competition here
MultiPlan Corporation (NYSE: MPLN)
ZCMD vs MPLN Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas MPLN's P/E ratio is -0.23. In terms of profitability, ZCMD's ROE is -0.32%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, ZCMD is more volatile compared to MPLN. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
ZCMD vs SLP Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, SLP has a market cap of 370.9M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while SLP trades at $18.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas SLP's P/E ratio is 20.84. In terms of profitability, ZCMD's ROE is -0.32%, compared to SLP's ROE of +0.06%. Regarding short-term risk, ZCMD is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SLP's competition here
Claritev Corporation (NYSE: CTEV)
ZCMD vs CTEV Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, CTEV has a market cap of 369.3M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while CTEV trades at $21.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas CTEV's P/E ratio is -1.66. In terms of profitability, ZCMD's ROE is -0.32%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, ZCMD is more volatile compared to CTEV. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CTEV's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
ZCMD vs TRHC Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas TRHC's P/E ratio is -4.27. In terms of profitability, ZCMD's ROE is -0.32%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, ZCMD is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check TRHC's competition here
So-Young International Inc. (NASDAQ: SY)
ZCMD vs SY Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, SY has a market cap of 253.2M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while SY trades at $1.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas SY's P/E ratio is -5.85. In terms of profitability, ZCMD's ROE is -0.32%, compared to SY's ROE of -0.16%. Regarding short-term risk, ZCMD is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SY's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
ZCMD vs SMFR Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas SMFR's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, ZCMD is more volatile compared to SMFR. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
ZCMD vs SPOK Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, SPOK has a market cap of 221.2M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while SPOK trades at $10.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas SPOK's P/E ratio is 17.65. In terms of profitability, ZCMD's ROE is -0.32%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, ZCMD is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
ZCMD vs AMWL Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, AMWL has a market cap of 179.4M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while AMWL trades at $10.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas AMWL's P/E ratio is -2.07. In terms of profitability, ZCMD's ROE is -0.32%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, ZCMD is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
ZCMD vs HCAT Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, HCAT has a market cap of 153.7M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while HCAT trades at $2.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas HCAT's P/E ratio is 10.40. In terms of profitability, ZCMD's ROE is -0.32%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, ZCMD is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
ZCMD vs CPSI Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas CPSI's P/E ratio is -183.80. In terms of profitability, ZCMD's ROE is -0.32%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, ZCMD is more volatile compared to CPSI. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
ZCMD vs OPRX Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, OPRX has a market cap of 117.1M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while OPRX trades at $6.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas OPRX's P/E ratio is 5.72. In terms of profitability, ZCMD's ROE is -0.32%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, ZCMD is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
ZCMD vs AUGX Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas AUGX's P/E ratio is -4.99. In terms of profitability, ZCMD's ROE is -0.32%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, ZCMD is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
ZCMD vs CCLD Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, CCLD has a market cap of 94.3M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while CCLD trades at $2.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas CCLD's P/E ratio is 8.22. In terms of profitability, ZCMD's ROE is -0.32%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, ZCMD is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
ZCMD vs DH Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, DH has a market cap of 72.4M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while DH trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas DH's P/E ratio is 2.64. In terms of profitability, ZCMD's ROE is -0.32%, compared to DH's ROE of -0.67%. Regarding short-term risk, ZCMD is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
ZCMD vs FORA Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas FORA's P/E ratio is -24.11. In terms of profitability, ZCMD's ROE is -0.32%, compared to FORA's ROE of -0.17%. Regarding short-term risk, ZCMD is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
ZCMD vs CCLDP Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas CCLDP's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, ZCMD is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
ZCMD vs ONMD Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, ONMD has a market cap of 35M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while ONMD trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas ONMD's P/E ratio is -4.10. In terms of profitability, ZCMD's ROE is -0.32%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, ZCMD is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
ZCMD vs SNCE Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas SNCE's P/E ratio is -0.27. In terms of profitability, ZCMD's ROE is -0.32%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, ZCMD is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
ZCMD vs AKLI Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas AKLI's P/E ratio is -0.71. In terms of profitability, ZCMD's ROE is -0.32%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, ZCMD is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
ZCMD vs SHLT Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas SHLT's P/E ratio is -3.87. In terms of profitability, ZCMD's ROE is -0.32%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, ZCMD is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
ZCMD vs SHCRW Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, ZCMD's ROE is -0.32%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, ZCMD is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SHCRW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
ZCMD vs EUDA Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, EUDA has a market cap of 28M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while EUDA trades at $14.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas EUDA's P/E ratio is -28.30. In terms of profitability, ZCMD's ROE is -0.32%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, ZCMD is more volatile compared to EUDA. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check EUDA's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
ZCMD vs ONMDW Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, ONMDW has a market cap of 27.8M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas ONMDW's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, ZCMD is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
ZCMD vs STRM Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas STRM's P/E ratio is -2.40. In terms of profitability, ZCMD's ROE is -0.32%, compared to STRM's ROE of -0.32%. Regarding short-term risk, ZCMD is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
ZCMD vs RNLX Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas RNLX's P/E ratio is -0.33. In terms of profitability, ZCMD's ROE is -0.32%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, ZCMD is more volatile compared to RNLX. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
ZCMD vs LIFW Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas LIFW's P/E ratio is -0.02. In terms of profitability, ZCMD's ROE is -0.32%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, ZCMD is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check LIFW's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
ZCMD vs BEATW Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, BEATW has a market cap of 15.9M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while BEATW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas BEATW's P/E ratio is -0.04. In terms of profitability, ZCMD's ROE is -0.32%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, ZCMD is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check BEATW's competition here
Babylon Holdings Limited (NYSE: BBLN)
ZCMD vs BBLN Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas BBLN's P/E ratio is -0.04. In terms of profitability, ZCMD's ROE is -0.32%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, ZCMD is more volatile compared to BBLN. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check BBLN's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
ZCMD vs ETAO Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas ETAO's P/E ratio is -0.01. In terms of profitability, ZCMD's ROE is -0.32%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, ZCMD is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
ZCMD vs BFRG Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, BFRG has a market cap of 7.1M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while BFRG trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas BFRG's P/E ratio is -1.12. In terms of profitability, ZCMD's ROE is -0.32%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, ZCMD is more volatile compared to BFRG. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check BFRG's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
ZCMD vs SCNX Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, SCNX has a market cap of 5.7M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while SCNX trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas SCNX's P/E ratio is -0.15. In terms of profitability, ZCMD's ROE is -0.32%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, ZCMD is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
ZCMD vs UPH Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas UPH's P/E ratio is -0.07. In terms of profitability, ZCMD's ROE is -0.32%, compared to UPH's ROE of -1.05%. Regarding short-term risk, ZCMD is more volatile compared to UPH. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
ZCMD vs UPH-WT Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, ZCMD is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check UPH-WT's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
ZCMD vs MGRX Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, MGRX has a market cap of 5.3M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while MGRX trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas MGRX's P/E ratio is -0.39. In terms of profitability, ZCMD's ROE is -0.32%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, ZCMD is more volatile compared to MGRX. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
ZCMD vs PEARW Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas PEARW's P/E ratio is -0.00. In terms of profitability, ZCMD's ROE is -0.32%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, ZCMD is more volatile compared to PEARW. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check PEARW's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
ZCMD vs PEAR Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas PEAR's P/E ratio is -0.08. In terms of profitability, ZCMD's ROE is -0.32%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, ZCMD is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check PEAR's competition here
Ontrak, Inc. (NASDAQ: OTRK)
ZCMD vs OTRK Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas OTRK's P/E ratio is -0.02. In terms of profitability, ZCMD's ROE is -0.32%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, ZCMD is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check OTRK's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
ZCMD vs HCTI Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, HCTI has a market cap of 1.9M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while HCTI trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas HCTI's P/E ratio is -0.21. In terms of profitability, ZCMD's ROE is -0.32%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, ZCMD is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
ZCMD vs CMAX Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas CMAX's P/E ratio is -0.00. In terms of profitability, ZCMD's ROE is -0.32%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, ZCMD is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CMAX's competition here
Aclarion, Inc. (NASDAQ: ACON)
ZCMD vs ACON Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while ACON trades at $2.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas ACON's P/E ratio is -0.23. In terms of profitability, ZCMD's ROE is -0.32%, compared to ACON's ROE of -0.54%. Regarding short-term risk, ZCMD is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check ACON's competition here
VSee Health, Inc. (NASDAQ: VSEE)
ZCMD vs VSEE Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, VSEE has a market cap of 1.3M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while VSEE trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas VSEE's P/E ratio is -0.15. In terms of profitability, ZCMD's ROE is -0.32%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, ZCMD is more volatile compared to VSEE. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check VSEE's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
ZCMD vs VSEEW Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, VSEEW has a market cap of 1.3M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, ZCMD's ROE is -0.32%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, ZCMD is more volatile compared to VSEEW. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
ZCMD vs LIFWZ Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, ZCMD is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
ZCMD vs EUDAW Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, EUDAW has a market cap of 922.5K. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, ZCMD's ROE is -0.32%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, ZCMD is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
ZCMD vs WORX Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, WORX has a market cap of 629.5K. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while WORX trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas WORX's P/E ratio is -0.69. In terms of profitability, ZCMD's ROE is -0.32%, compared to WORX's ROE of -0.65%. Regarding short-term risk, ZCMD is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
ZCMD vs MSPRZ Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, ZCMD is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
ZCMD vs KERN Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas KERN's P/E ratio is -0.01. In terms of profitability, ZCMD's ROE is -0.32%, compared to KERN's ROE of -0.17%. Regarding short-term risk, ZCMD is more volatile compared to KERN. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
ZCMD vs KERNW Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas KERNW's P/E ratio is -0.00. In terms of profitability, ZCMD's ROE is -0.32%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, ZCMD is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
ZCMD vs LIFWW Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas LIFWW's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, ZCMD is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
ZCMD vs CMAXW Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas CMAXW's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, ZCMD is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
ZCMD vs ACONW Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, ACONW has a market cap of 11.9K. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas ACONW's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, ZCMD is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check ACONW's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
ZCMD vs SMFRW Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas SMFRW's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to SMFRW's ROE of -0.28%. Regarding short-term risk, ZCMD is more volatile compared to SMFRW. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check SMFRW's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
ZCMD vs MTBCO Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas MTBCO's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, ZCMD is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check MTBCO's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
ZCMD vs MSPRV Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas MSPRV's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to MSPRV's ROE of N/A. Regarding short-term risk, ZCMD is more volatile compared to MSPRV. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check MSPRV's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
ZCMD vs CNVY Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, CNVY has a market cap of 0. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas CNVY's P/E ratio is -71.50. In terms of profitability, ZCMD's ROE is -0.32%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, ZCMD is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CNVY's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
ZCMD vs MTBCP Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas MTBCP's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, ZCMD is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
ZCMD vs MTBC Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, MTBC has a market cap of 0. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas MTBC's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, ZCMD is more volatile compared to MTBC. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
ZCMD vs CHNG Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, CHNG has a market cap of 0. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas CHNG's P/E ratio is -152.72. In terms of profitability, ZCMD's ROE is -0.32%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, ZCMD is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CHNG's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
ZCMD vs IMS Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, IMS has a market cap of 0. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas IMS's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to IMS's ROE of +0.27%. Regarding short-term risk, ZCMD is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check IMS's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
ZCMD vs KURIU Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, KURIU has a market cap of 0. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas KURIU's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, ZCMD is more volatile compared to KURIU. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check KURIU's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
ZCMD vs CHNGU Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas CHNGU's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, ZCMD is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check CHNGU's competition here
Cue Health Inc. (NASDAQ: HLTH)
ZCMD vs HLTH Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, HLTH has a market cap of 0. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while HLTH trades at $25.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas HLTH's P/E ratio is N/A. In terms of profitability, ZCMD's ROE is -0.32%, compared to HLTH's ROE of +0.00%. Regarding short-term risk, ZCMD is more volatile compared to HLTH. This indicates higher risk in terms of short-term price fluctuations for ZCMD.Check HLTH's competition here
NantHealth, Inc. (NASDAQ: NH)
ZCMD vs NH Comparison July 2026
Zhongchao Inc. (NASDAQ: ZCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ZCMD stands at 48.6K. In comparison, NH has a market cap of 0. Regarding current trading prices, ZCMD is priced at $1.40 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ZCMD currently has a P/E ratio of -0.05, whereas NH's P/E ratio is -0.12. In terms of profitability, ZCMD's ROE is -0.32%, compared to NH's ROE of +0.35%. Regarding short-term risk, ZCMD is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for ZCMD.Check NH's competition here